Lonza Group reported 2.63B in Current Liabilities for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 6017M 547M
Alcon AG ALC:SW 2.25B 225M
AstraZeneca AZN:LN 21815M 925M
BASF BAS:GR € 26633M 1540M
Bayer BAYN:GR € 33643M 2624M
Covestro 1COV:GR 4.14B 346M
Fresenius FRE:GR € 14300M 162M
Fresenius Medical Care FME:GR € 6877M 499.55M
Genmab GEN:DC DK 1339M 229M
Givaudan GIVN:VX 2.87B 554M
GlaxoSmithKline GSK:LN 37835M 13557M
GN Store Nord GN:DC DK 8749M 2607M
Hikma Pharmaceutical HIK:LN 1.01B 6M
Johnson Matthey JMAT:LN 3.15B 425M
Merck MRK:GR € 9718M 489M
Novartis NOVN:VX SF 27646M 2161M
Solvay SOLB:BB € 7079M 499M
William Demant Holding WDH:DC 10.97B 1.5B